Long-term follow-up of children exposed in utero to antineoplastic agents

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.

Breast (Edinburgh, Scotland)·2022

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Seminars in oncology·2026

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Seminars in oncology·2026

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Tumour-proximal deep serum proteomics identifies biomarkers associated with ovarian cancer.

Molecular oncology·2026

The Serotonergic and Cholinergic Signaling Pathways Drive Gastric Precancerous Lesions and Its Potential Mechanism.

Cancer science·2026

An Integrative Multi-Omic Biomarker Panel Distinguishes Hepatocellular Carcinoma From Chronic Liver Disease in HBV-Predominant Populations.

Hepatology research : the official journal of the Japan Society of Hepatology·2026

Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer.

BJS open·2026

Effect of uric acid and estimated glomerular filtration rate on the Fibrosis-4 index: A cross-sectional and cohort analysis.

Medicine·2026

Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study.

Medicine·2026

Related Experiment Videos

Long-term follow-up of children exposed in utero to antineoplastic agents

Related Concept Videos

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study.

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors.

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Tumour-proximal deep serum proteomics identifies biomarkers associated with ovarian cancer.

The Serotonergic and Cholinergic Signaling Pathways Drive Gastric Precancerous Lesions and Its Potential Mechanism.

An Integrative Multi-Omic Biomarker Panel Distinguishes Hepatocellular Carcinoma From Chronic Liver Disease in HBV-Predominant Populations.

Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer.

Effect of uric acid and estimated glomerular filtration rate on the Fibrosis-4 index: A cross-sectional and cohort analysis.

Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study.

Related Experiment Videos

Long-term follow-up of children exposed in utero to antineoplastic agents

Related Concept Videos

Related Articles